A prognostic indicator of survival in metastatic colorectal cancer patients in the era of molecular-targeted agents: the modified Glasgow Prognostic Score.
about
The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients.An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.
P2860
A prognostic indicator of survival in metastatic colorectal cancer patients in the era of molecular-targeted agents: the modified Glasgow Prognostic Score.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A prognostic indicator of surv ...... fied Glasgow Prognostic Score.
@en
A prognostic indicator of surv ...... fied Glasgow Prognostic Score.
@nl
type
label
A prognostic indicator of surv ...... fied Glasgow Prognostic Score.
@en
A prognostic indicator of surv ...... fied Glasgow Prognostic Score.
@nl
prefLabel
A prognostic indicator of surv ...... fied Glasgow Prognostic Score.
@en
A prognostic indicator of surv ...... fied Glasgow Prognostic Score.
@nl
P2093
P2860
P356
P1433
P1476
A prognostic indicator of surv ...... fied Glasgow Prognostic Score.
@en
P2093
Catherine Brezault
Johann Dreanic
Marion Dhooge
Romain Coriat
Stanislas Chaussade
P2860
P356
10.1159/000356879
P50
P577
2013-12-20T00:00:00Z